Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cel
Sponsor: NRG Oncology
Check if you qualify for this prostate cancer clinical trial in Beverly Hills, CA
If you're searching for prostate cancer treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.